Guangdong Research Development vs Total Revenue Analysis

603983 Stock

27.63 0.18 0.65%

Guangdong Marubi financial indicator trend analysis is much more than just examining Guangdong Marubi Bio latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Guangdong Marubi Bio is a good investment. Please check the relationship between Guangdong Marubi Research Development and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Guangdong Marubi Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Research Development vs Total Revenue

Research Development vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Guangdong Marubi Bio Research Development account and Total Revenue. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Guangdong Marubi's Research Development and Total Revenue is 0.97. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Guangdong Marubi Biotechnology, assuming nothing else is changed. The correlation between historical values of Guangdong Marubi's Research Development and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Guangdong Marubi Biotechnology are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Research Development i.e., Guangdong Marubi's Research Development and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.97

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Research Development

Total Revenue

Total revenue comprises all receipts Guangdong Marubi Bio generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Guangdong Marubi's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Guangdong Marubi Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Guangdong Marubi Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 52.3 M, whereas Selling General Administrative is forecasted to decline to about 798.9 M.

	2021	2022	2023	2024 (projected)
Net Interest Income	34.1M	14.0M	15.1M	24.6M
Tax Provision	68.4M	39.2M	39.5M	52.3M

Net Interest Income Tax Provision

Guangdong Marubi fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Common Stock Shares Outstanding	Net Invested Capital
Total Assets		-0.72	0.65	1.0	-0.16	0.97	0.99	0.48	0.36	0.87	0.81	0.87	-0.36	0.48	0.88	0.74	-0.83	0.71	-0.21	0.78	0.9	0.77	0.92	0.64	0.9	1.0
Other Current Liab	-0.72		-0.64	-0.69	-0.03	-0.58	-0.68	-0.77	-0.1	-0.69	-0.4	-0.64	0.1	-0.67	-0.71	-0.93	0.78	-0.8	0.37	-0.63	-0.59	-0.8	-0.77	-0.65	-0.72	-0.72
Total Current Liabilities	0.65	-0.64		0.6	-0.09	0.63	0.6	0.67	0.36	0.48	0.34	0.57	-0.57	0.03	0.69	0.54	-0.41	0.94	0.05	0.47	0.66	0.39	0.83	0.42	0.56	0.61
Total Stockholder Equity	1.0	-0.69	0.6		-0.15	0.97	0.99	0.44	0.36	0.86	0.82	0.87	-0.35	0.47	0.87	0.71	-0.83	0.66	-0.22	0.79	0.9	0.76	0.9	0.62	0.91	1.0
Other Liab	-0.16	-0.03	-0.09	-0.15		-0.07	-0.12	0.35	0.56	-0.46	-0.5	-0.48	-0.41	-0.05	0.22	-0.25	0.32	-0.16	-0.51	0.36	0.15	-0.29	-0.22	-0.4	-0.15	-0.19
Net Tangible Assets	0.97	-0.58	0.63	0.97	-0.07		0.97	0.41	0.55	0.74	0.8	0.82	-0.53	0.34	0.89	0.55	-0.67	0.64	-0.15	0.81	0.96	0.59	0.85	0.43	0.88	0.96
Retained Earnings	0.99	-0.68	0.6	0.99	-0.12	0.97		0.49	0.37	0.86	0.83	0.87	-0.39	0.44	0.86	0.7	-0.82	0.64	-0.2	0.82	0.89	0.76	0.88	0.6	0.89	0.99
Accounts Payable	0.48	-0.77	0.67	0.44	0.35	0.41	0.49		0.3	0.37	0.14	0.36	-0.48	0.3	0.56	0.62	-0.44	0.69	-0.13	0.63	0.48	0.46	0.53	0.37	0.39	0.44
Cash	0.36	-0.1	0.36	0.36	0.56	0.55	0.37	0.3		-0.12	0.12	0.07	-0.87	-0.01	0.6	-0.16	0.17	0.27	-0.05	0.57	0.71	-0.24	0.21	-0.38	0.3	0.33
Non Current Assets Total	0.87	-0.69	0.48	0.86	-0.46	0.74	0.86	0.37	-0.12		0.82	0.87	0.06	0.55	0.58	0.83	-0.95	0.59	-0.17	0.56	0.56	0.9	0.82	0.87	0.74	0.88
Non Currrent Assets Other	0.81	-0.4	0.34	0.82	-0.5	0.8	0.83	0.14	0.12	0.82		0.93	-0.17	0.37	0.46	0.52	-0.71	0.39	0.13	0.58	0.61	0.61	0.64	0.45	0.73	0.83
Other Assets	0.87	-0.64	0.57	0.87	-0.48	0.82	0.87	0.36	0.07	0.87	0.93		-0.2	0.37	0.59	0.73	-0.83	0.62	0.08	0.61	0.68	0.76	0.82	0.58	0.86	0.89
Net Receivables	-0.36	0.1	-0.57	-0.35	-0.41	-0.53	-0.39	-0.48	-0.87	0.06	-0.17	-0.2		0.3	-0.54	0.1	-0.12	-0.39	-0.22	-0.54	-0.66	0.17	-0.32	0.29	-0.3	-0.32
Non Current Liabilities Total	0.48	-0.67	0.03	0.47	-0.05	0.34	0.44	0.3	-0.01	0.55	0.37	0.37	0.3		0.37	0.67	-0.6	0.35	-0.33	0.36	0.31	0.58	0.29	0.47	0.41	0.51
Inventory	0.88	-0.71	0.69	0.87	0.22	0.89	0.86	0.56	0.6	0.58	0.46	0.59	-0.54	0.37		0.61	-0.61	0.71	-0.37	0.76	0.95	0.58	0.85	0.43	0.84	0.86
Other Current Assets	0.74	-0.93	0.54	0.71	-0.25	0.55	0.7	0.62	-0.16	0.83	0.52	0.73	0.1	0.67	0.61		-0.92	0.72	-0.23	0.47	0.49	0.94	0.78	0.81	0.75	0.75
Other Stockholder Equity	-0.83	0.78	-0.41	-0.83	0.32	-0.67	-0.82	-0.44	0.17	-0.95	-0.71	-0.83	-0.12	-0.6	-0.61	-0.92		-0.54	0.29	-0.57	-0.54	-0.99	-0.8	-0.86	-0.8	-0.85
Total Liab	0.71	-0.8	0.94	0.66	-0.16	0.64	0.64	0.69	0.27	0.59	0.39	0.62	-0.39	0.35	0.71	0.72	-0.54		0.0	0.46	0.65	0.53	0.84	0.55	0.61	0.68
Deferred Long Term Liab	-0.21	0.37	0.05	-0.22	-0.51	-0.15	-0.2	-0.13	-0.05	-0.17	0.13	0.08	-0.22	-0.33	-0.37	-0.23	0.29	0.0		-0.42	-0.2	-0.31	-0.21	-0.3	-0.19	-0.19
Short Long Term Debt	0.78	-0.63	0.47	0.79	0.36	0.81	0.82	0.63	0.57	0.56	0.58	0.61	-0.54	0.36	0.76	0.47	-0.57	0.46	-0.42		0.81	0.5	0.63	0.29	0.68	0.76
Total Current Assets	0.9	-0.59	0.66	0.9	0.15	0.96	0.89	0.48	0.71	0.56	0.61	0.68	-0.66	0.31	0.95	0.49	-0.54	0.65	-0.2	0.81		0.48	0.8	0.28	0.85	0.88
Intangible Assets	0.77	-0.8	0.39	0.76	-0.29	0.59	0.76	0.46	-0.24	0.9	0.61	0.76	0.17	0.58	0.58	0.94	-0.99	0.53	-0.31	0.5	0.48		0.78	0.86	0.77	0.78
Common Stock	0.92	-0.77	0.83	0.9	-0.22	0.85	0.88	0.53	0.21	0.82	0.64	0.82	-0.32	0.29	0.85	0.78	-0.8	0.84	-0.21	0.63	0.8	0.78		0.71	0.86	0.9
Property Plant Equipment	0.64	-0.65	0.42	0.62	-0.4	0.43	0.6	0.37	-0.38	0.87	0.45	0.58	0.29	0.47	0.43	0.81	-0.86	0.55	-0.3	0.29	0.28	0.86	0.71		0.48	0.63
Common Stock Shares Outstanding	0.9	-0.72	0.56	0.91	-0.15	0.88	0.89	0.39	0.3	0.74	0.73	0.86	-0.3	0.41	0.84	0.75	-0.8	0.61	-0.19	0.68	0.85	0.77	0.86	0.48		0.92
Net Invested Capital	1.0	-0.72	0.61	1.0	-0.19	0.96	0.99	0.44	0.33	0.88	0.83	0.89	-0.32	0.51	0.86	0.75	-0.85	0.68	-0.19	0.76	0.88	0.78	0.9	0.63	0.92

Click cells to compare fundamentals

Guangdong Marubi Account Relationship Matchups

Guangdong Marubi fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.4B	3.8B	3.8B	4.1B	4.5B	3.4B
Other Current Liab	296.0M	369.6M	349.8M	4.5M	20.0M	19.0M
Total Current Liabilities	740.0M	786.6M	576.5M	668.5M	1.0B	790.0M
Total Stockholder Equity	2.7B	3.0B	3.1B	3.2B	3.3B	2.5B
Other Liab	25.6M	26.4M	7.8M	12.0M	10.8M	14.4M
Net Tangible Assets	1.3B	2.7B	3.0B	2.3B	2.7B	2.0B
Retained Earnings	1.5B	1.8B	1.9B	1.8B	2.0B	1.5B
Accounts Payable	212.8M	203.1M	198.4M	229.8M	262.6M	246.6M
Cash	2.1B	1.7B	806.1M	1.1B	1.1B	1.0B
Non Current Assets Total	307.9M	1.1B	1.8B	1.9B	1.9B	1.1B
Non Currrent Assets Other	4.1M	742.5M	530.4M	469.1M	304.8M	282.4M
Other Assets	38.3M	40.9M	798.8M	562.0M	646.3M	678.6M
Net Receivables	5.6M	5.2M	57.4M	69.8M	28.0M	38.2M
Non Current Liabilities Total	26.4M	7.8M	26.6M	173.1M	25.0M	44.2M
Inventory	187.0M	138.3M	138.4M	151.7M	171.7M	156.2M
Other Current Assets	33.5M	42.4M	222.9M	474.7M	442.7M	464.8M
Other Stockholder Equity	(74.5K)	(62.3K)	(285.9K)	(1.3M)	(1.1M)	(1.1M)
Total Liab	766.4M	794.4M	603.2M	841.6M	1.0B	838.7M
Deferred Long Term Liab	16.7M	7.3M	21.2M	10.0M	11.5M	13.6M
Total Current Assets	3.1B	2.7B	2.0B	2.2B	2.5B	2.3B
Intangible Assets	17.7M	18.6M	764.6M	748.6M	719.6M	755.6M
Property Plant Equipment	260.3M	249.3M	246.0M	384.1M	441.8M	308.7M
Net Invested Capital	2.7B	3.1B	3.1B	3.4B	3.4B	2.8B
Net Working Capital	2.4B	1.9B	1.4B	1.6B	1.5B	1.7B

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

Other Information on Investing in Guangdong Stock

Balance Sheet is a snapshot of the financial position of Guangdong Marubi Bio at a specified time, usually calculated after every quarter, six months, or one year. Guangdong Marubi Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Guangdong Marubi and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Guangdong currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Guangdong Research Development vs Total Revenue Analysis

Research Development vs Total Revenue

Research Development vs Total Revenue Correlation Analysis

Correlation Coefficient

Research Development

Total Revenue

Guangdong Marubi fundamental ratios Correlations

Guangdong Marubi Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Guangdong Marubi fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Guangdong Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Retained Earnings	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity
Net Invested Capital	+ 0.99	Retained Earnings

Intangible Assets	- 0.99	Other Stockholder Equity
Other Stockholder Equity	- 0.95	Non Current Assets Total
Other Current Assets	- 0.93	Other Current Liab
Other Stockholder Equity	- 0.92	Other Current Assets
Net Receivables	- 0.87	Cash
Property Plant Equipment	- 0.86	Other Stockholder Equity